Admission Date:  [**2130-3-9**]       Discharge Date:  [**2130-3-29**]  Date of Birth:   [**2054-6-9**]       Sex:  F  Service:  HISTORY OF THE PRESENT ILLNESS:  The patient is a 75-year-old woman admitted to the Neurosurgery Service on [**2130-3-9**] for planned craniotomy for resection of brain metastases with lung versus renal cell carcinoma.
The patient was loaded with Decadron and Dilantin and transferred to the [**Hospital6 2018**] from an outside hospital.
The patient was being preopped for a craniotomy and then on [**2130-3-13**], the patient was more confused, had spiked to 101.2 up to 103.2 and then noted to desaturate with an ABG 7.32, 52, 67 on 3 liters.
Right nephrectomy for renal cell carcinoma 20 years ago.
The patient was covered empirically for nosocomial pathogens with vancomycin, ceftazidime, and levofloxacin.
He also had problems with thrombocytopenia.
[**Name2 (NI) 6196**] thought to be a possible cause was discontinued and the patient was not on any other medications thought to be related to this problem.
The patient remained intubated and was finally extubated on [**2130-3-22**] on a 50% face mask and her sepsis resolved.
She was on antibiotics for a total of seven days.
She underwent a left temporal craniotomy for tumor resection without intraoperative complication.
She was seen by Physical Therapy and Occupational Therapy and found to require acute rehabilitation.
She was discharged to rehabilitation in stable condition with follow-up in the Brain [**Hospital 341**] Clinic in two weeks for staple removal.
Nystatin swish and swallow 5 cc p.o.
Lisinopril 10 p.o.
Furosemide 40 p.o.
Decadron currently 4 p.o.
Metoprolol 50 p.o.
Percocet one to two tablets p.o.
Tylenol 650 p.o.
Pantoprazole 40 mg p.o.
Calcium carbonate 5 mg p.o.
Keppra 500 mg p.o.
Synthroid 112 micrograms NG q.d.
Colace 100 mg p.o.
Sarna lotion one application topically q. three to four hours p.r.n.
Insulin sliding scale.
FOLLOW-UP:  The patient will follow-up in the Brain [**Hospital 341**] Clinic in two weeks for staple removal and follow-up.
